206 related articles for article (PubMed ID: 7602463)
41. [Biodegradable microparticles with immobilized peptide for wound healing].
Stashevskaia KS; Markvicheva EA; Strukova SM; Rusanova AV; Makarova AM; Gorbacheva LR; Prudchenko IA; Zubov VP; Grandfis K
Biomed Khim; 2006; 52(1):83-94. PubMed ID: 16739924
[TBL] [Abstract][Full Text] [Related]
42. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
[TBL] [Abstract][Full Text] [Related]
43. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
[TBL] [Abstract][Full Text] [Related]
44. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
Péan JM; Boury F; Venier-Julienne MC; Menei P; Proust JE; Benoit JP
Pharm Res; 1999 Aug; 16(8):1294-9. PubMed ID: 10468034
[TBL] [Abstract][Full Text] [Related]
45. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
46. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
47. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
48. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
49. Submicronparticles from biodegradable polymers.
Jobmann M; Rafler G
Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
[TBL] [Abstract][Full Text] [Related]
50. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Pollauf EJ; Kim KK; Pack DW
J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
[TBL] [Abstract][Full Text] [Related]
51. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
Passerini N; Craig DQ
J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
[TBL] [Abstract][Full Text] [Related]
52. Preparation and characterization of poly(D,L-lactic-co-glycolic Acid) microspheres containing flurbiprofen sodium.
Samati Y; Yüksel N; Tarimci N
Drug Deliv; 2006; 13(2):105-11. PubMed ID: 16423798
[TBL] [Abstract][Full Text] [Related]
53. Modulation of polyplex release from biodegradable microparticles through poly(ethylenimine) modification and varying loading concentration.
Needham CJ; Shah SR; Mountziaris PM; Kasper FK; Mikos AG
Pharm Res; 2014 Jan; 31(1):77-85. PubMed ID: 23884567
[TBL] [Abstract][Full Text] [Related]
54. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
55. In vitro evaluation of gentamicin released from microparticles.
Blanco-Príeto MJ; Lecaroz C; Renedo MJ; Kunkova J; Gamazo C
Int J Pharm; 2002 Aug; 242(1-2):203-6. PubMed ID: 12176247
[TBL] [Abstract][Full Text] [Related]
56. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
57. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
[TBL] [Abstract][Full Text] [Related]
58. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
[TBL] [Abstract][Full Text] [Related]
59. Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system.
Engwicht A; Girreser U; Müller BW
Int J Pharm; 1999 Aug; 185(1):61-72. PubMed ID: 10425366
[TBL] [Abstract][Full Text] [Related]
60. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.
Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M
Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
